Lipopolysaccharide (LPS), which is expressed on the outer membrane of gram-negative bacteria, has a wide variety of biological (endotoxic) and immunological effects (reviewed in reference 15). The molecule consists of three main regions: hydrophilic polysaccharide side chains, or 0 antigens; a central core polysaccharide; and a hydrophobic section, lipid A, which is responsible for the insertion of the LPS molecule into the bacterial membrane (12) . The 0 polysaccharides are highly variable among different strains of bacteria, and both polyclonal and monoclonal (3) antibodies specific for the 0 antigens have been generated which can distinguish various strains serologically. The core polysaccharides, which are also immunogenic, are more structurally conserved between strains. Antibodies to core polysaccharides, therefore, cross-react within larger groups of bacteria (6) . Lipid A, whose structure is highly conserved within members of the family Enterobacteriaceae, is responsible for most of the biological effects associated with endotoxin. Among these effects are toxicity (15) , pyrogenicity (15), macrophage activation (22) , and polyclonal B-cell activation (1) . Recent studies with synthetic lipid A analogs have indicated that different chemical features of the lipid A molecule may be responsible for different endotoxin activities (12), as was previously suggested when the biological activities of natural lipid A molecules of different origins (and structures) were compared (11) .
Although purified lipid A has proven to be a poor immunogen, antibodies to lipid A have been generated in rabbits by injection of Re mutant Salmonella minnesota R595 bacterial cells which were acid treated to expose the lipid A (7) or after incorporation of lipid A into liposomes (19) . Studies with rabbit anti-lipid A antibodies have suggested that the immunodominant area of the molecule involves the linkage region of the amide-linked fatty acids and the glucosamine backbone, but it is unknown whether this is a single or multiple antigenic determinant(s) or if other determinants contribute significantly to antigenicity (6) . Anti-lipid A antibodies have been more difficult to produce in mice. A recent report has shown that antibodies can be detected after two injections of mice with acid-treated bacteria, spaced 4 weeks apart (6) . Only nonspecific polyclonal responses were induced by purified lipid A (6). Monoclonal anti-lipid A antibodies would obviously be of great use in probing structure-function relationships of the lipid A molecule, as well as in identifying antigenic determinants on the molecule. However, only one preliminary report (W. C. Bogard, * Corresponding author.
Jr., K. Abernathy, D. L. Dunn, and P. C. Kung, Fed. Proc. 46:1682, 1984) has described such hybridomas, which were isolated after immunization of mice with heat-killed bacteria. In this paper we describe an immunoglobulin G3 anti-lipid A monoclonal antibody which was produced after immunization of mice with purified lipid A.
BALB/cByJ female mice (Jackson Laboratories, Bar Harbor, Maine) received four weekly intraperitoneal injections of a sonicated solution containing 40 ,ug of rat skeletal muscle microsomal fraction and 25 ,ug of lipid A (Calbiochem-Behring Corp., La Jolla, Calif.; less than 0.16% 2-keto-3-deoxyoctulosonic acid). Three days after injection four, spleens were removed and fused with SP2/0-Ag 14 myeloma cells (20) with polyethylene glycol 1000 as previously described (10) . The original intent of this experiment was to generate monoclonal antibodies specific for cell membrane molecules of rat skeletal muscle. To increase the immunogenicity of the antigen preparation, we included lipid A in the inoculum as an adjuvant. However, no specific monoclonal antibodies were generated against the rat skeletal muscle microsomal fraction. Therefore, the culture supernatants of growing clones were reanalyzed for the presence of anti-lipid A antibodies by a modification of the indirect radioimmunoassay previously described (14) in which wells of polyvinyl chloride plates (Dynatech Laboratories, Inc., Alexandria, Va.) were coated with 50 RI of a sonicated, 20-,ig/ml solution of lipid A (1 p,g per well) in 0.05 M carbonate buffer (5) overnight at 4°C. Coating of the wells with lipid A was confirmed (data not shown) with a rabbit anti-lipid A antibody that was the generous gift of Carl Alving (19) . Positive wells were expanded and subcloned by limiting dilution (23) . A stable, anti-lipid A positive subclone, 2G6/1H11, was determined to be of the immunoglobulin G3 isotype by an isotype-specific radioimmunoassay as previously described (3) . Ascites of the 2G6/1H11 antibody (as well as a control immunoglobulin G3 anti-O antigen monoclonal antibody, H3A11 [3] ), was produced in pristaneprimed BALB/cByJ mice, precipitated with 50% ammonium sulfate, and affinity purified with protein A-Sepharose (4). These affinity-purified antibodies were visualized as single bands on a Coomassie blue-stained 7% sodium dodecyl sulfate-polyacrylamide gel. The binding of the affinity-purified antibodies to whole bacteria (Salmonella typhimurium TML [9, 14] ), purified TML LPS (14, 18) , purified lipid A, or purified lipid A precursor (1 p.g per well, coated as above for lipid A [21] ) was then assessed. In addition, the binding of these monoclonal antibodies to a panel of LPS preparations purified from rough (R) mutants of S. minnesota, as well as (14) .
The data presented in Table 1 show that 2G6/1H11 binds purified lipid A and the lipid A precursor, even at very low concentrations. Thus, the determinant recognized must be shared by these two molecules, both derived from Salmonella species (S. minnesota and S. typhimurium, respectively). This eliminates 2-keto-3-deoxyoctulosonic acid, arabinose, phosphorylethanolamine, lauryl acid, or myristoyl acid residues as being critical parts of the antigenic determinant (a direct comparison of the proposed structures is shown in Fig. 1 [21] ). Preliminary results indicate that 2G6/1H11 binds lipid A purified from Escherichia coli K235 (a gift of Stefanie Vogel, Uniformed Services University of the Health Sciences [USUHS]) as well as lipid A from S. minnesota (Table 1) ; the structures of the two molecules are presumably very similar (11) . Examination of the antibody binding to lipid A from other, different bacteria or to synthetic lipid A analogs will be necessary to identify the specificity more precisely. However, 2G6/1H11 bound purified TML LPS very poorly in comparison with the binding to purified lipid A. Virtually no binding to intact S. typhimurium (TML) was observed. This was true even when higher concentrations of antibody were added to the wells (data not shown). The assay used here fixed whole bacteria to the wells with glutaraldehyde (14) , indicating that the lipid A antigenic determinant is not exposed even after the glutaraldehyde treatment. Conversely, H3A11, which is specific for the 0 antigens 1, 4, and 12 of S. typhimurium (3), bound TML and purified TML LPS but neither of the lipid A preparations. Table 2 illustrates the binding of 2G6/1H11 to the panel of S. minnesota R mutant LPS preparations at a concentration of 300 ng per well. Higher antibody concentrations resulted in only slightly higher counts bound, with a concomitant increase in nonspecific binding (by the control antibody H3A11). Only low levels of binding to any of these mutant LPS preparations were observed, and these low levels decreased to background levels upon dilution to approximately 10 ng per well.
The binding patterns of the monoclonal anti-lipid A antibody described here confirm and extend observations made previously with polyclonal anti-lipid A antibodies. Several lines of evidence have suggested that the antigenic determinants of lipid A are not exposed on the surface of intact bacteria, even in R mutants. Fluorescence studies with rabbit anti-lipid A antibodies have shown little reaction with intact smooth strains (16) or with rough strains of Salmonella (9) . Furthermore, lipid A/anti-lipid A antibody interactions are not inhibited by Formalin-killed smooth or rough bacteria (13) . Conversely, antibodies to lipid A are not detected in antisera generated against intact bacteria (9, 13), with the possible exception of sera generated by hyperimmunization with an Re mutant (7). Our results, using a sensitive radioimmunoassay (14) and the anti-lipid A 2G6/1H11 monoclonal antibody, demonstrate conclusively that the antigenic determinant recognized by this antibody is not available for binding on the surface of S. typhimurium or even purified S. typhimurium LPS or S. minnesota LPS.
Previous studies have demonstrated that anti-lipid A antibodies cross-react with lipid A from many gram-negative bacteria (11), suggesting common determinants that might be exploited for vaccination. However, our studies, coupled with previous work (7, 9, 13, 16) , suggest that these determinants may be unavailable for recognition in intact bacteria. This in turn would explain the failure to demonstrate significant protection against infection by immunization with lipid A (2) or passive transfer of anti-lipid A antibodies (16) . Nonetheless, experiments to evaluate the efficacy of passive transfer of 2G6/1H11 in protection against infection with S. typhimurium (17) are in progress. Of greater potential importance is the use of monoclonal antibodies to lipid A to identify the determinants responsible for the various biological effects of the molecule. Experiments are in progress to determine the capacity of 2G6/1H11 to inhibit lipid A-induced B-cell mitogenesis and interleukin 1 induction.
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